8-K current report · filed Oct 22, 2026

UNITED THERAPEUTICS Corp (UTHR) 8-K Current Report: October 22, 2026

Item 8.01Item EX-99.1UTHR overview

Short answer

UNITED THERAPEUTICS Corp (UTHR) filed an 8-K current report with the SEC on October 22, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). $2.0 billion share repurchase authorization approved, signaling substantial capital return to shareholders.

UNITED THERAPEUTICS Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • $2.0 billion share repurchase authorization approved, signaling substantial capital return to shareholders
  • Program runs through October 21, 2027, providing flexibility on repurchase timing
  • Potential share-count reduction and enhanced per-share metrics, depending on execution
  • Exhibit 99.1 contains the company’s announcement and additional program details

Item EX-99.1 · Exhibit EX-99.1

  • New $2 billion repurchase authorization available through October 21, 2027
  • Capital-return capacity signals management confidence and prioritizes buybacks alongside long-term investment
  • Purchases may use ASRs, open-market or private transactions, with no minimum commitment
  • Existing September 2026 ASR remains outstanding and will not reduce the new authorization
  • Buyback execution remains discretionary, dependent on market conditions and alternative capital uses

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other UNITED THERAPEUTICS Corp 8-K filings

Get the next UTHR 8-K as it lands

Follow UTHR for push alerts, or ask the research agent what this filing means.